Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
7.51
+0.01 (0.13%)
At close: Jan 26, 2026, 4:00 PM EST
7.49
-0.02 (-0.27%)
Pre-market: Jan 27, 2026, 4:00 AM EST
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $548.13 million as of January 27, 2026. Its market cap has increased by 142.98% in one year.
Market Cap
548.13M
Enterprise Value
433.83M
1-Year Change
142.98%
Ranking
Category
Stock Price
$7.51
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $548.13M, an increase of 102.00%. That is a compound annual growth rate of 37.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 548.13M | -24.37% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 584.95M |
| Design Therapeutics | 579.89M |
| CorMedix | 572.80M |
| Ginkgo Bioworks Holdings | 569.50M |
| Forte Biosciences | 568.82M |
| Kyverna Therapeutics | 557.58M |
| Ocugen | 544.29M |
| Prothena Corporation | 538.30M |